Profusa, Inc.

Profusa, Inc. (ticker: NVAC) is a medical technology company focused on implantable continuous biosensing platforms designed to monitor tissue oxygen and other in-body biomarkers in real time. The company operates in the healthcare and digital health sector and filed a quarterly report on Form 10-Q with the SEC on November 10, 2022, covering activity as a public reporting entity. Profusa reached the public markets through a SPAC transaction and has continued to file periodic reports under the NVAC ticker. For comprehensive filing history, financial summaries, and deal details tied to NVAC, sign up for full access on SpacDesk, the research platform built for SPAC investors and analysts.